436 related articles for article (PubMed ID: 7465432)
41. Chromium 51 EDTA/technetium 99m MDP plasma ratio to measure total skeletal function.
Nisbet AP; Edwards S; Lazarus CR; Malamitsi J; Maisey MN; Mashiter GD; Winn PJ
Br J Radiol; 1984 Aug; 57(680):677-80. PubMed ID: 6235885
[TBL] [Abstract][Full Text] [Related]
42. [Biokinetics of osteotropic radiopharmaceuticals in metabolic osteopathy--comparison of 47Ca and 99mTc-methylene-diphosphonate (MDP)].
Knop J; Montz R
Nuklearmedizin; 1983 Oct; 22(5):226-31. PubMed ID: 6228781
[TBL] [Abstract][Full Text] [Related]
43. Validation of a blood-sampling method for the measurement of 99mTc-methylene diphosphonate skeletal plasma clearance.
Moore AE; Blake GM; Fogelman I
J Nucl Med; 2006 Apr; 47(4):581-6. PubMed ID: 16595490
[TBL] [Abstract][Full Text] [Related]
44. Diffuse abdominal uptake of technetium-99m-methylene diphosphonate in a patient on continuous ambulatory dialysis during bone scintigraphy.
McDevitt GR; Heironimus JD; Toney MO; Billingsley JL
J Nucl Med; 1992 Nov; 33(11):2052-4. PubMed ID: 1432173
[TBL] [Abstract][Full Text] [Related]
45. Electrophoretic analysis of different technetium-99m (SnCl2) methylene diphosphonate complexes.
Najafi A; Hutchison N
J Nucl Med; 1985 May; 26(5):524-30. PubMed ID: 3157787
[TBL] [Abstract][Full Text] [Related]
46. Multiple tracer studies of bone uptake of 99mTc-MDP and 85Sr.
McCarthy ID; Hughes SP
Am J Physiol; 1989 May; 256(5 Pt 2):H1261-5. PubMed ID: 2719126
[TBL] [Abstract][Full Text] [Related]
47. [The kidneys and urinary tracts, as demonstrated by skeletal scintigraphy with 99m technetium-methyl diphosphonate (author's transl)].
Crone-Münzebrock W
Rofo; 1980 Jul; 133(1):75-8. PubMed ID: 6451535
[TBL] [Abstract][Full Text] [Related]
48. [Extraosseous accumulation of 99mTc-phosphate complexes (author's transl)].
Takebayashi S; Ono Y; Odagiri K; Nakamori A; Asakura K; Matsui K; Tanaka T; Oikawa Y; Yamamoto Y
Kaku Igaku; 1981 Nov; 18(9):1207-15. PubMed ID: 6461788
[No Abstract] [Full Text] [Related]
49. Early dynamic bone-imaging as an indicator of osseous blood flow and factors affecting the uptake of 99mTc hydroxymethylene diphosphonate in healing bone.
Nutton RW; Fitzgerald RH; Kelly PJ
J Bone Joint Surg Am; 1985 Jun; 67(5):763-70. PubMed ID: 3997929
[TBL] [Abstract][Full Text] [Related]
50. Computer analysis of Tc-99m DPD and Tc-99m MDP kinetics in humans: concise communication.
Mele M; Conte E; Fratello A; Pasculli D; Pieralice M; D'Addabbo A
J Nucl Med; 1983 Apr; 24(4):334-8. PubMed ID: 6834136
[TBL] [Abstract][Full Text] [Related]
51. Tc-99m MDP and indium-111 chloride scintigraphy in skeletal tuberculosis.
Nocera RM; Sayle B; Rogers C; Wilkey D
Clin Nucl Med; 1983 Sep; 8(9):418-20. PubMed ID: 6227442
[TBL] [Abstract][Full Text] [Related]
52. Technetium-99m-labeled stannous imidodiphosphate, a new radiodiagnostic agent for bone scanning: comparison with other 99mTc complexes.
Subramanian G; McAfee JG; Blair RJ; Rosenstreich M; Coco M; Duxbury CE
J Nucl Med; 1975 Dec; 16(12):1137-43. PubMed ID: 1194964
[TBL] [Abstract][Full Text] [Related]
53. Studies on diphosphonate kinetics. Part II: Whole body bone uptake rate during constant infusion--a refined index of bone metabolism.
Hyldstrup L; McNair P; Ring P; Henriksen O
Eur J Nucl Med; 1987; 12(12):585-8. PubMed ID: 3107991
[TBL] [Abstract][Full Text] [Related]
54. [Magistral preparation of methylene diphosphonate and its clinical evaluation in radionuclide diagnosis of the skeleton].
Lepej J; Marosová A; Altmann P; Reznák I; Podmajerský M
Cesk Farm; 1989 Jul; 38(5):204-9. PubMed ID: 2790989
[TBL] [Abstract][Full Text] [Related]
55. [Value and limitations of scintigraphy based on methylene diphosphonate pyrophosphate labeled with 99m technetium in the monitoring of revascularized bone transplants].
Clouet M; Chavoin JP; Vigoni F; Pessey JJ; Costagliola M
Ann Chir Plast; 1981; 26(3):217-20. PubMed ID: 6458230
[No Abstract] [Full Text] [Related]
56. A comparison between the diagnostic efficacy of 99mTc-MDP, 99mTc-DPD and 99mTc-HDP for the detection of bone metastases.
Pauwels EK; Blom J; Camps JA; Hermans J; Rijke AM
Eur J Nucl Med; 1983; 8(3):118-22. PubMed ID: 6220908
[TBL] [Abstract][Full Text] [Related]
57. [Clinical comparison of the kinetics of 99mTc pyrophosphate and 99mTc methylene diphosphonate (author's transl)].
Casara D; Cimitan M; Zorat P; Calzavara F
Radiol Med; 1979; 65(1-2):67-70. PubMed ID: 223200
[TBL] [Abstract][Full Text] [Related]
58. Extra-skeletal uptake of bone agents.
Morton KA
J Nucl Med Technol; 1999 Mar; 27(1):51-3. PubMed ID: 10322578
[No Abstract] [Full Text] [Related]
59. [The radiation dose to children bone scintigraphy with 99mTc-phosphate compounds (author's transl)].
Eissner D; Wolf R
Rofo; 1980 Mar; 132(3):331-5. PubMed ID: 6253368
[TBL] [Abstract][Full Text] [Related]
60. Quantitative studies of bone using (18)F-fluoride and (99m)Tc-methylene diphosphonate: evaluation of renal and whole-blood kinetics.
Park-Holohan SJ; Blake GM; Fogelman I
Nucl Med Commun; 2001 Sep; 22(9):1037-44. PubMed ID: 11505214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
